Dirk Sibbing’s Editorial on Sex Differences in DAPT De-escalation After PCI
Dirk Sibbing, Professor, Cardiologist and Angiologist at Lauterbacher Mill Private Clinic and LMU Munich, shared a post on LinkedIn:
“More insights into treatment effect modifiers of dual antiplatelet therapy (DAPT)!
Sex matters, and we are moving more and more towards a more personalized antiplatelet treatment post PCI
See the coverage on TCTMD on the great paper by Mattia Galli in EHJ and my accompanying Editorial.”
Title: Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis
Authors: Giovanni Occhipinti, Claudio Laudani, Mattia Galli, Luis Ortega-Paz, Vijay Kunadian, Guiomar Mendieta, Riccardo Rinaldi, Felicita Andreotti, Roxana Mehran, Teresa López-Sobrino, Davide Capodanno, Dominick J Angiolillo, Manel Sabaté Tenas, Salvatore Brugaletta
Read the full paper here.
Check for the Editorial here.
Stay updated with Hemostasis Today.
-
Feb 20, 2026, 17:35Wolfgang Miesbach: Plasma FIX Is Only Part of the Story In Haemophilia B
-
Feb 20, 2026, 17:27Sheharyar Raza: Examining Guideline Discordance in Evidence-Based Apheresis Recommendations
-
Feb 20, 2026, 17:23Barbara Mora: Newly Discovered EPO Gene Intronic Variant as a Cause of Congenital Erythrocytosis
-
Feb 20, 2026, 16:48Miguel Brito: Newborn Screening and Challenges in Follow-Up Care for Sickle Cell Disease in Angola
-
Feb 20, 2026, 16:41Uche Kennedy: Hemophilia Care Needs Systems Reform, Not Short-Term Fixes
-
Feb 20, 2026, 16:33Sonal Sonu: Real Clinical Maturity is Knowing When to Stop
-
Feb 20, 2026, 16:27Clear Recommendations for Daily Management and Family Support in Hemophilia A – WFH
-
Feb 20, 2026, 15:56Alan Nurden: Highlighting the Role of Activated Platelets in Heart and Kidney Complications of Diabetes
-
Feb 20, 2026, 15:51Domenico Girelli: Continuing Commitment to Rare Disease Research